Different age groups may get different Covid vaccines, experts say

Oxford/AstraZeneca planning new trial of lower-dose jab to see how well it works in older people

Concerns around the efficacy of the Oxford University/AstraZeneca coronavirus jab in older people could lead to different age groups being given different vaccines, experts have said.

The partners announced last week that the vaccine had a 70% efficacy overall. For most trial participants – given two full doses, spaced a month apart – the efficacy was 62%, but for 3,000 participants mistakenly given half a dose for their first jab, the efficacy was 90%. No participants, regardless of dosing, developed severe Covid or were hospitalised with the disease.

Continue reading...

Sudan says it will stamp out child marriage and enforce ban on FGM

Police told to enforce law against cutting girls passed in July as country says it will adhere to African charter on child rights

Sudanese authorities have announced they will end child marriage and enforce the country’s ban on female genital mutilation (FGM), in a major step forward for the rights of women and girls.

Police officers were told on Wednesday they must inform local communities that FGM is illegal following new laws passed in July that make it punishable by up to three years in jail.

Continue reading...

Boris Johnson: ‘If we ease off now, we risk losing control of this virus’ – video

Boris Johnson said he was sorry that most of England would exit lockdown into tiers 2 or 3 with the toughest restrictions. Johnson said the measures 'strike a balance' between limiting the spread of the virus and protecting freedoms. 'If we ease off now, we risk losing control of this virus,' Johnson added.

Chris Whitty, the government’s chief medical adviser, urged people to 'have sense' over the festive period, and bluntly warned against hugging and kissing elderly relatives at Christmas

Continue reading...

Most of England to enter two toughest tiers when lockdown is lifted

Signs of growing parliamentary rebellion amid fears measures could stay in place until spring

The majority of England will enter the two toughest tiers of Covid restrictions from next week, ministers are set to announce, amid signs of a growing parliamentary rebellion and fears that the measures could remain unchanged until spring.

On Thursday Matt Hancock, the health secretary, is expected to say that most of the country will be placed into tiers 2 or 3, which imply significant restrictions on hospitality, after the national lockdown ends on 2 December.

Continue reading...

Christmas and Covid: is mixing households a good idea?

The UK says three households can get together for festivities. Four Britons react – with relief, caution and despair

The UK government’s announcement to allow three households to meet together over five days at Christmas has attracted differing opinions. Many people fear that relaxing lockdown poses too great a risk to life, others are pleased they can see their family after being apart so long. One in four, according to a poll last weekend, would probably treat Christmas as they do normally, despite any restrictions.

The Guardian spoke to four people about their response to the news.

Continue reading...

UK scientists warn of third wave of Covid after Christmas

Fears easing restrictions over festive period will lead to rise in cases and overwhelm NHS

Government scientists have warned the relaxation of coronavirus restrictions over Christmas could lead to a third wave of the pandemic, with increased transmission and unnecessary deaths.

Families across the UK will be able to gather in three-household groups of any size over Christmas, the government has announced, prompting warnings from scientists that the plan will almost inevitably result in a rise in the number of coronavirus cases.

Continue reading...

Families bereaved by Covid say UK plan to allow Christmas mixing is ‘sheer madness’

Support group warns that large gatherings are too risky and calls for low-key festive period

People bereaved by Covid-19 have warned that allowing families in the UK to get together over Christmas is “sheer madness” and urged the public to have a low-key festive period rather than risk the grief they have endured.

Members of the Covid-19 Bereaved Families for Justice group told the Guardian that large family gatherings were too high-risk, with one grieving husband saying anyone prepared to mix family groups should also “prepare for a funeral”.

Continue reading...

A vaccine revolution | podcast

Results from clinical trials have shown that the world has three apparently highly effective vaccines for Covid-19. With the race now on for regulatory approval, production and distribution, is the end of the pandemic within reach?

After a gruelling year of successive waves of Covid-19 infections and national lockdowns there has been a burst of good news this month, with three separate vaccine candidates performing extremely well in clinical trials.

First, Pfizer and Moderna announced that their vaccines were testing at an efficacy of around 95%. Then came the news that the AstraZeneca vaccine (the one pre-ordered in bulk by the UK government) was hitting 90%. It marks not just a new phase in the Covid-19 pandemic but potentially a revolution in vaccine technology itself.

Continue reading...

Michael Gove announces relaxation of Covid measures over Christmas – video

Families across the UK will be able to gather in three-household groups of any size over Christmas, Michael Gove announced, after the heads of the devolved governments agreed on a relaxation of Covid restrictions over the festive period.

The long-planned idea of 'Christmas bubbles' – which Gove insisted demonstrated a 'cautious approach' – was thrashed out in a meeting involving the four UK nations. It will allow people to travel around freely from 23 to 27 December, irrespective of what local tier of Covid restrictions they live in.

Continue reading...

The five-day Christmas Covid bubble: how will it work?

New rules will mean you can’t change your bubble but there is no maximum size for the three permitted households

The government has announced that up to three households will be able to mix indoors and stay with each other overnight from 23 to 27 December under loosened coronavirus restrictions across the UK. But how exactly will these new “Christmas bubbles” work?

Continue reading...

Five days of Christmas UK Covid plan lets groups of three households mix

Four UK governments agree relaxed rules, and scientists expect rise in cases to follow

Families across the UK will be able to gather in three-household groups of any size over Christmas, the government has announced, bringing warnings from scientists that the plan will almost inevitably see a rise in the number of coronavirus cases.

The long-planned idea of “Christmas bubbles” – which ministers said would require people to make a “personal judgment” over risk for older relatives and others – was thrashed out in a meeting involving the four UK governments.

Continue reading...

I’m a survivor! How resilience became the quality we all crave

During the pandemic it has become a buzzword for successfully steering through adversity. But what exactly is resilience - and can you cultivate more of it?

It was after her block of flats burned down that Sadi Khan thought, finally, things could not get worse. She had married at 19, and for four years her husband had subjected her to horrific violence on an almost daily basis. She had been punched and kicked, financially controlled and constantly told she was stupid; once, a friend arrived at her flat and found her lying unconscious after an attack. So the day she accidentally set fire to her flat while cooking was simultaneously the day she lost everything and the day she started again. “He’s beaten me, I’ve lost everything,” she says. “What more can go wrong?”

Her father arrived the following day, and wanted to take her home. “I think that was the turning point,” says Khan. “When my dad was in front of me, saying: ‘Come home, let me look after you.’ I thought: ‘No, I don’t need looking after. I’m still alive. I burned the flat down, I’m still alive. I’ve been beaten up, I should have been dead five times over, but I’m still alive.’”

Continue reading...

Vaccine results bring us a step closer to ending Covid, says Oxford scientist

Latest breakthrough comes as PM says he hopes most at-risk could be immunised by Easter

The world is moving a step closer to ending the coronavirus pandemic, the scientist behind Britain’s first vaccine has declared, as Boris Johnson said he hoped the majority of those most at-risk could be immunised by Easter.

Successful trial results for the Oxford University/AstraZeneca vaccine, suggesting it could protect up to 90% of people, are the third set of promising findings in as many weeks. Before this year, there had never been a vaccine for a coronavirus.

Continue reading...

Oxford AstraZeneca vaccine to be sold to developing countries at cost price

Jab that is part of global initiative to distribute doses will remain at low price ‘in perpetuity’

The coronavirus vaccine produced by Oxford University and AstraZeneca will be available on a non-profit basis “in perpetuity” to low- and middle-income countries in the developing world.

The details of arrangements to supply poorer countries came as AstraZeneca revealed the interim results of a phase 3 trial of the vaccine, which is being heralded as the first to meet the more challenging requirements of the developing world.

Continue reading...

The Covid vaccine results are great news, but it’s not all over yet

Oxford/AstraZeneca findings have certain advantages over those from other versions

Within weeks, the prospects of an end to the pandemic have changed utterly, with three vaccines against Covid-19 reporting good results in final clinical trials and at least one likely to be used before Christmas. But there are still huge challenges ahead.

The results from the Oxford University/AstraZeneca vaccine, which is absolutely central to the UK’s vaccination strategy, may at first glance look not as good as those of Pfizer/BioNTech and Moderna – the two mRNA vaccines that have both reported 95% efficacy.

Continue reading...

Oxford AstraZeneca Covid vaccine has up to 90% efficacy, data reveals

Vaccine developed in UK by AstraZeneca and Oxford University ‘will save many lives’, says scientist

A coronavirus vaccine developed in the UK can prevent 70.4% of people from getting Covid-19 and up to 90% if a lower dose is used, according to data.

Oxford University and AstraZeneca have announced their jab is effective in preventing many people getting ill and it has been shown to work in different age groups, including the elderly. There are early indications it might also help stop the spread of the disease.

Continue reading...

Ice Bucket Challenge co-creator Patrick Quinn dies aged 37

Quinn credited with boosting ‘greatest social media campaign in history’, raising more than $220m for ALS research

Patrick Quinn, whose personal battle with Lou Gehrig’s disease helped power the Ice Bucket Challenge fundraising campaign, has died aged 37, seven years after his diagnosis, according to the ALS Association and his supporters on Facebook.

Quinn, who was born and grew up in Yonkers, New York, was co-founder of the campaign that raised more than $220m for medical research into amyotrophic lateral sclerosis (ALS), more commonly known as Lou Gehrig’s disease. He was diagnosed with ALS on 8 March 2013.

Continue reading...

Majority of Australian voters in favour of pill testing, election data shows

Long-running study finds 63% of voters support drug minimisation strategy shunned by governments

Nearly two-thirds of the Australian public are in favour of pill testing at music festivals, new national data shows.

The findings, drawn from the Australian National University’s long-running election study, show strong public support for a drug harm minimisation strategy that has largely been shunned by governments across the country despite high-profile cases of deaths at music festivals.

Continue reading...

Is this the beginning of an mRNA vaccine revolution? | Adam Finn

No one knew whether mRNA technology would work against this virus – but it does. It’s an extraordinary moment for science

The past few months have brought a number of scientific terms to public attention. We’ve had to digest R (a virus’s reproduction number) and PCR (the polymerase chain reaction method of testing). And now there’s mRNA. This last one has featured heavily in recent news reports because of the spectacular results of two new mRNA vaccines against coronavirus. It stands for “messenger ribonucleic acid”, a label familiar enough if you studied biology at O-level or GCSE, but otherwise hardly a household name. Even in the field of vaccine research, if you had said as recently as 10 years ago that you could protect people from infections by injecting them with mRNA, you would have provoked some puzzled looks.

Essentially, mRNA is a molecule used by living cells to turn the gene sequences in DNA into the proteins that are the building blocks of all their fundamental structures. A segment of DNA gets copied (“transcribed”) into a piece of mRNA, which in turn gets “read” by the cell’s tools for synthesising proteins. In the case of an mRNA vaccine, the virus’s mRNA is injected into the muscle, and our own cells then read it and synthesise the viral protein. The immune system reacts to these proteins – which can’t by themselves cause disease – just as if they’d been carried in on the whole virus. This generates a protective response that, we hope, lasts for some time. It’s so beautifully simple it almost seems like science fiction. But last week we learned that it was true.

Continue reading...

Why the race to find Covid-19 vaccines is far from over

Despite the promising news from Pfizer and Moderna, other efforts – which may be even more effective – continue around the world

While everyone celebrated this month’s news that not one but two experimental vaccines against Covid-19 have proved at least 90% effective at preventing disease in late-stage clinical trials, research into understanding how the Sars-CoV-2 virus, which causes Covid-19, interacts with the human immune system never paused.

There are plenty of questions still to answer about the Pfizer/BioNTech and Moderna vaccines: how well will they protect the elderly, for example, and how long for? Which aspects of the immune response that they elicit are protective and which aren’t? Can even better results be achieved, with vaccines that target different parts of the immune system?

Continue reading...